• News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Small Cell Lung Cancer Treatment

  • Imdelltra Available for Treatment of  Extensive Stage Small Cell Lung Cancer
    November 17, 2025

    Imdelltra Available for Treatment of Extensive Stage Small Cell Lung Cancer

    Charles H. Weaver, MD
  • Recent Updates on Imdelltra in Extensive Stage Small Cell Lung Cancer
    October 8, 2024

    Recent Updates on Imdelltra in Extensive Stage Small Cell Lung Cancer

    Charles H. Weaver, MD
  • ASCO 2024 – Major Advances in the Treatment of Lung Cancer
    August 18, 2024

    ASCO 2024 – Major Advances in the Treatment of Lung Cancer

    Charles H. Weaver, MD
  • Benmelstobart Immunotherapy for Small Cell Lung Cancer
    September 23, 2023

    Benmelstobart Immunotherapy for Small Cell Lung Cancer

    Charles H. Weaver, MD
  • The Antibody Drug Conjugate Iflinatamab Deruxtecan is Active in SCLC
    September 18, 2023

    The Antibody Drug Conjugate Iflinatamab Deruxtecan is Active in SCLC

    Charles H. Weaver, MD
  • Antibody Drug Conjugate ABBV-011 Targeting SEZ6 in Small Cell Lung Cancer
    August 28, 2023

    Antibody Drug Conjugate ABBV-011 Targeting SEZ6 in Small Cell Lung Cancer

    Charles H. Weaver, MD
  • BI 764532 Bispecific Antibody for DLL3 Small Cell Lung Cancer
    June 23, 2023

    BI 764532 Bispecific Antibody for DLL3 Small Cell Lung Cancer

    Charles H. Weaver, MD
  • Zepzelca (Lurbinectedin) in Small Cell Lung Cancer
    June 16, 2020

    Zepzelca (Lurbinectedin) in Small Cell Lung Cancer

    Charles H. Weaver, MD
  • Is Lung Cancer Different in Non or Never-Smokers?
    November 18, 2019

    Is Lung Cancer Different in Non or Never-Smokers?

    Charles H. Weaver, MD
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
 

Loading Comments...